Work

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Year: 2000

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: R S Freedman, A P Kudelka, J J Kavanagh, C Verschraegen, C L Edwards, M Nash, L Levy, E N Atkinson, H Z Zhang, B Melichar, R Patenia, S Templin, W Scott, C D Platsoucas

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: General Clinical Research Center, OVARIAN CARCINOMA TIL TREATMENT AFTER IFN GAMMA/IL2

OpenAlex ID: W2112736971

FWCI: 3.119

Cites: 29

Cited by: 94

Related to: 10